Compile Data Set for Download or QSAR
Report error Found 2060 of affinity data for UniProtKB/TrEMBL: P31639
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM734330(US20250129055, Compound 2)
Affinity DataIC50: 0.105nMAssay Description:1. Materials and methods(1) MaterialsThe humanized SGLT2 overexpression cells (CHO-SGLT2) constructed from Chinese hamster ovary (CHO) cells were cul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50448927(CHEMBL3125318 | US20250129055, Control Dapaglifloz...)
Affinity DataIC50: 0.147nMAssay Description:1. Materials and methods(1) MaterialsThe humanized SGLT2 overexpression cells (CHO-SGLT2) constructed from Chinese hamster ovary (CHO) cells were cul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555248(USRE49080, Example 16)
Affinity DataIC50: 0.150nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555251(USRE49080, Example 21)
Affinity DataIC50: 0.200nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555247(USRE49080, Example 15)
Affinity DataIC50: 0.200nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555242(USRE49080, Example 8)
Affinity DataIC50: 0.25nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50321299((2S,3R,4R,5S,6R)-2-(4-chloro-5-(4-ethylbenzyl)-2-(...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of human SGLT2 expressed in HEK293 cells assessed as inhibition of [14C]alpha-methyl-D-glucopyranoside uptake after 1.5 hrs by liquid scin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2010
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50303246((1S,3'R,4'S,5'S,6'R)-5-chloro-6'-(hydroxymethyl)-6...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of human SGLT2 transfected in HEK293.ETN cells assessed as AMG uptake after 1.5 hrs by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159472(US9034921, E114)
Affinity DataIC50: 0.308nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555255(USRE49080, Example 28)
Affinity DataIC50: 0.330nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555263(USRE49080, Example 42)
Affinity DataIC50: 0.350nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50614494(CHEMBL5288495)
Affinity DataIC50: 0.350nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM734429(US20250129055, Compound 8)
Affinity DataIC50: 0.356nMAssay Description:1. Materials and methods(1) MaterialsThe humanized SGLT2 overexpression cells (CHO-SGLT2) constructed from Chinese hamster ovary (CHO) cells were cul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159516(US9034921, E158 | US9340521, E024)
Affinity DataIC50: 0.366nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159528(US9034921, E171 | US9340521, E028)
Affinity DataIC50: 0.366nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159516(US9034921, E158 | US9340521, E024)
Affinity DataIC50: 0.370nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159528(US9034921, E171 | US9340521, E028)
Affinity DataIC50: 0.370nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells by methyl-alpha-D-glucopyranoside assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159528(US9034921, E171 | US9340521, E028)
Affinity DataIC50: 0.370nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159520(US9034921, E162 | US9340521, E026)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555252(USRE49080, Example 22)
Affinity DataIC50: 0.400nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159520(US9034921, E162 | US9340521, E026)
Affinity DataIC50: 0.404nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159387(US9034921, E001 | US9340521, E001)
Affinity DataIC50: 0.440nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells by methyl-alpha-D-glucopyranoside assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159387(US9034921, E001 | US9340521, E001)
Affinity DataIC50: 0.440nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159458(US9034921, E098)
Affinity DataIC50: 0.454nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159529(US9034921, E172)
Affinity DataIC50: 0.460nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells by methyl-alpha-D-glucopyranoside assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159529(US9034921, E172)
Affinity DataIC50: 0.463nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM228482(US9340521, E029)
Affinity DataIC50: 0.470nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159474(US9034921, E116)
Affinity DataIC50: 0.475nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM228491(US9340521, E043)
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of [14C]alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintilla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells by methyl-alpha-D-glucopyranoside assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2011
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 assessed as inhibition of methyl-alpha-D-glucopyranoside uptake by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2010
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM228499(US9340521, E051)
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human recombinant SGLT2 expressed in CHO cells by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/28/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/24/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2011
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM20880(CHEMBL429910 | C-aryl glucoside, 6 | BMS-512148 | ...)
Affinity DataIC50: 0.490nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation counterMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2011
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50560402(Licogliflozin | Lik066 | LIK-066 | USRE49080, Exam...)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of SGLT2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM50560402(Licogliflozin | Lik066 | LIK-066 | USRE49080, Exam...)
Affinity DataIC50: 0.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM228496(US9340521, E048)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159468(US9034921, E110)
Affinity DataIC50: 0.504nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159394(US9034921, E008 | US9340521, E006)
Affinity DataIC50: 0.550nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM555250(USRE49080, Example 20)
Affinity DataIC50: 0.550nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159599(US9034921, E242 | US9340521, E036)
Affinity DataIC50: 0.550nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5×104 cells/well...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2017
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159394(US9034921, E008 | US9340521, E006)
Affinity DataIC50: 0.551nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159471(US9034921, E113)
Affinity DataIC50: 0.551nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159599(US9034921, E242 | US9340521, E036)
Affinity DataIC50: 0.552nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Beijing Increase Innovative Drug

US Patent
LigandPNGBDBM159537(US9034921, E180)
Affinity DataIC50: 0.574nMpH: 7.4 T: 2°CAssay Description:For sodium-dependent glucose transport assay, cells expressing hSGLT2 were seeded into a 96-well culture plate at a density of 5x104 cells/well in RP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/8/2015
Entry Details
US Patent

Displayed 1 to 50 (of 2060 total ) | Next | Last >>
Jump to: